Answer
Evkeeza (evinacumab) is indicated for homozygous familial hypercholesterolaemia in adults and children aged 6 months and older, as an adjunct to diet and other LDL-cholesterol-lowering therapies.
Sources for this answer
- Evkeeza 150 mg/ml concentrate for solution for infusionUltragenyx UK · emc · SmPC §4.1 Therapeutic Indications · Version 4Document updated
Sources checked